HSF1 and B-cell chronic lymphocytic leukemia: Our findings suggest an involvement of HSP70/HSF1 axis in controlling pharmacological resistance to ibrutinib in CLL cells, since their inhibition is effective in inducing in vitro apoptosis in cells from ibrutinib refractory patients.